Data / Federal awards / NAICS 325412 / Department of Veterans Affairs
Department of Veterans Affairs contracts under NAICS 325412 Pharmaceutical Preparation Manufacturing: $32.8 billion to 758 recipients (FY2024 to FY2027)
Updated October 6, 2026. Source: USAspending.gov.
Department of Veterans Affairs obligated $32.8 billion under NAICS 325412, Pharmaceutical Preparation Manufacturing, across 5,763 contract awards to 758 named recipients in fiscal years 2024 to 2027. The largest recipients are MCKESSON CORPORATION ($32.1 billion), PROGENICS PHARMACEUTICALS INC ($106.3 million), EXELAN PHARMACEUTICALS INC ($103.5 million). 13 opportunities under this code are open on SAM.gov now.
The request: Every federal contract awarded by Department of Veterans Affairs under NAICS 325412, with the winner, the value and the period of performance. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- Agency
- Department of Veterans Affairs
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Contract awards
- 5,763
- Obligated
- $32.8 billion
- Named recipients
- 758
- Small business share of obligations
- 1%
- Full and open competition share
- 99%
- Set aside share
- 0%
- Latest action
- 2026-10-02
Open opportunities in this niche
The same code on SAM.gov, read each morning: 13 opportunities you can still respond to.
Incumbents at this agency
Ranked by dollars obligated in fiscal years 2024 to 2027.
| Recipient | Business size | Awards | Obligated | Share |
|---|---|---|---|---|
| MCKESSON CORPORATION | Other Than Small Business | 102 | $32.06 billion | 97.7% |
| PROGENICS PHARMACEUTICALS INC | Small Business | 153 | $106.3 million | 0.3% |
| EXELAN PHARMACEUTICALS INC | Other Than Small Business | 114 | $103.5 million | 0.3% |
| CARDINAL HEALTH 414, LLC | Other Than Small Business | 373 | $77.1 million | 0.2% |
| NOVARTIS PHARMACEUTICALS CORPORATION | Other Than Small Business | 60 | $54.5 million | 0.2% |
| ADVANCED ACCELERATOR APPLICATIONS USA INC | Small Business | 86 | $30.9 million | 0.1% |
| SOFIE CO. | Small Business | 70 | $29.6 million | 0.1% |
| BRISTOL-MYERS SQUIBB COMPANY | Other Than Small Business | 112 | $20.9 million | 0.1% |
| RLS (USA) INC. | Small Business | 70 | $19.5 million | 0.1% |
| FFF ENTERPRISES, INC. | Other Than Small Business | 1 | $16.4 million | 0.1% |
| GOLDEN STATE MEDICAL SUPPLY, INC. | Small Business | 170 | $16 million | 0.0% |
| JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | Small Business | 92 | $15.3 million | 0.0% |
| PETNET SOLUTIONS, INC. | Small Business | 81 | $15.1 million | 0.0% |
| PHARMACY BUYING ASSOCIATION, INC. | Small Business | 84 | $13.1 million | 0.0% |
| MEDI-PHYSICS, INC. | Other Than Small Business | 115 | $11.4 million | 0.0% |
| BRACCO DIAGNOSTICS INC. | Other Than Small Business | 33 | $11.2 million | 0.0% |
| BOSTON SCIENTIFIC CORP | Other Than Small Business | 44 | $10.9 million | 0.0% |
| TELIX PHARMACEUTICALS US INC | Small Business | 19 | $9.1 million | 0.0% |
| SANOFI VACCINES US INC. | Other Than Small Business | 49 | $6.7 million | 0.0% |
| NUCLEAR DIAGNOSTIC PRODUCTS, INC | Small Business | 23 | $6.3 million | 0.0% |
| OPTUM INFUSION SERVICES 308, LLC | Other Than Small Business | 31 | $6.2 million | 0.0% |
| NATIONWIDE PHARMACEUTICAL LLC | Small Business | 38 | $5.7 million | 0.0% |
| OPTUM PHARMACY 801, INC. | Other Than Small Business | 84 | $5.1 million | 0.0% |
| JAZZ PHARMACEUTICALS, INC | Other Than Small Business | 58 | $4.6 million | 0.0% |
| PHARMALOGIC HOLDINGS CORP. | Small Business | 22 | $4.6 million | 0.0% |
| KOFFEL MEDICAL SUPPLY INC | Small Business | 11 | $4.2 million | 0.0% |
| TRILLAMED LLC | Small Business | 56 | $4.1 million | 0.0% |
| PRIORITY HEALTHCARE DISTRIBUTION INC | Other Than Small Business | 27 | $4.1 million | 0.0% |
| NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC | Small Business | 8 | $4.1 million | 0.0% |
| MELLING LLC | Small Business | 40 | $4 million | 0.0% |
| SEQIRUS USA INC | Other Than Small Business | 32 | $3.9 million | 0.0% |
| MID-AMERICA ISOTOPES, INC | Small Business | 5 | $3.7 million | 0.0% |
| SCHAAF DRUGS, LLC | Small Business | 20 | $3.6 million | 0.0% |
| UNITED THERAPEUTICS CORP | Small Business | 188 | $3.6 million | 0.0% |
| AMICUS THERAPEUTICS US, LLC | Small Business | 76 | $3.5 million | 0.0% |
| WOODS INTERNATIONAL LLC | Small Business | 23 | $3.4 million | 0.0% |
| BAYLOR COLLEGE OF MEDICINE | Other Than Small Business | 4 | $3.4 million | 0.0% |
| CENTRAL ADMIXTURE PHARMACY SERVICES, INC | Other Than Small Business | 47 | $3.3 million | 0.0% |
| CLINICAL PHARMACY SERVICES, INC. | Small Business | 3 | $3.2 million | 0.0% |
| HARMONY BIOSCIENCES LLC | Small Business | 60 | $3.1 million | 0.0% |
| ACTELION PHARMACEUTICALS US, INC. | Other Than Small Business | 45 | $3 million | 0.0% |
| VALNEVA USA, INC. | Small Business | 7 | $2.8 million | 0.0% |
| ALEXION PHARMACEUTICALS INC | Other Than Small Business | 9 | $2.7 million | 0.0% |
| ASE DIRECT, INC. | Small Business | 45 | $2.6 million | 0.0% |
| UNIVERSITY OF OKLAHOMA | Other Than Small Business | 8 | $2.6 million | 0.0% |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | Other Than Small Business | 68 | $2.5 million | 0.0% |
| D & R PHARMACEUTICAL SERVICES, LLC | Other Than Small Business | 6 | $2.5 million | 0.0% |
| MERCK SHARP & DOHME LLC | Other Than Small Business | 67 | $2.3 million | 0.0% |
| GUARDIAN PHARMACY OF TENNESSEE ONE, LLC | Other Than Small Business | 2 | $2.3 million | 0.0% |
| CORE TRADING CO | Small Business | 25 | $2.2 million | 0.0% |
Offices buying
| Sub agency | Awards | Obligated |
|---|---|---|
| Department of Veterans Affairs | 5,763 | $32.83 billion |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $8.82 billion |
| FY2025 | $11.66 billion |
| FY2026 | $12.29 billion |
| FY2027 | $65.9 million |
Products and services bought
| Code | Product or service | Awards | Obligated |
|---|---|---|---|
| 6505 | Drugs and Biologicals | 5,298 | $32.77 billion |
| 6515 | Medical and Surgical Instruments, Equipment, and Supplies | 121 | $21.8 million |
| Q527 | Medical- Nuclear Medicine | 32 | $11 million |
| Q517 | Pharmacy Services | 104 | $8.1 million |
| 6525 | Imaging Equipment and Supplies: Medical, Dental, Veterinary | 28 | $5.5 million |
| 6550 | In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | 41 | $4.3 million |
| 3650 | Chemical and Pharmaceutical Products Manufacturing Machinery | 30 | $3.6 million |
| Q301 | Reference Laboratory Testing | 7 | $1.9 million |
Largest contract awards
| Award ID | Recipient | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 36C24026K1002 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER | $1,406,868,182 | $1,406,868,182 | November 1, 2025 | November 30, 2025 | Irving, TX | usaspending.gov |
| 36C24026K1008 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY | $1,398,025,092 | $1,398,025,092 | May 1, 2026 | May 30, 2026 | Irving, TX | usaspending.gov |
| 36C24026K1010 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY | $1,194,619,137 | $1,194,619,137 | July 1, 2026 | July 31, 2026 | Irving, TX | usaspending.gov |
| 36C24026K1009 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JUNE | $1,191,973,258 | $1,191,973,258 | June 1, 2026 | June 30, 2026 | Irving, TX | usaspending.gov |
| 36C24026K1007 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL | $1,191,348,081 | $1,191,348,081 | April 1, 2026 | April 30, 2026 | Irving, TX | usaspending.gov |
| 36C24026K1001 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER | $1,184,200,532 | $1,184,200,532 | October 1, 2025 | October 31, 2025 | Irving, TX | usaspending.gov |
| 36C24025K1012 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER | $1,177,854,443 | $1,177,854,443 | September 1, 2025 | September 30, 2025 | Irving, TX | usaspending.gov |
| 36C24026K1006 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH | $1,175,683,451 | $1,175,683,451 | March 1, 2026 | March 31, 2026 | Irving, TX | usaspending.gov |
| 36C24025K1010 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JULY | $1,118,034,560 | $1,118,034,560 | July 1, 2025 | July 31, 2025 | Irving, TX | usaspending.gov |
| 36C24026K1003 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER | $1,110,402,104 | $1,110,402,104 | December 1, 2025 | December 31, 2025 | Irving, TX | usaspending.gov |
| 36C24026K1004 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY | $1,087,989,766 | $1,087,989,766 | January 1, 2026 | January 31, 2026 | Irving, TX | usaspending.gov |
| 36C24025K1011 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 AUGUST | $1,075,377,430 | $1,075,377,430 | August 1, 2025 | August 30, 2025 | Irving, TX | usaspending.gov |
| 36C24026K1005 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 FEBRUARY | $1,060,268,795 | $1,060,268,795 | February 1, 2026 | February 28, 2026 | Irving, TX | usaspending.gov |
| 36C24025K1001 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 OCTOBER | $1,047,972,072 | $1,047,972,072 | October 1, 2024 | October 31, 2024 | Irving, TX | usaspending.gov |
| 36C24025K1007 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 APRIL | $1,045,889,952 | $1,045,889,952 | April 1, 2025 | April 30, 2025 | Irving, TX | usaspending.gov |
| 36C24025K1008 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MAY | $1,043,484,625 | $1,043,484,625 | May 1, 2025 | May 30, 2025 | Irving, TX | usaspending.gov |
| 36C24025K1009 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JUNE | $1,020,312,793 | $1,020,312,793 | June 1, 2025 | June 30, 2025 | Irving, TX | usaspending.gov |
| 36C24025K1006 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 MARCH | $999,993,461 | $999,993,461 | March 1, 2025 | March 31, 2025 | Irving, TX | usaspending.gov |
| 36C24024K1010 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JULY | $971,836,194 | $971,836,194 | July 1, 2024 | July 31, 2024 | Irving, TX | usaspending.gov |
| 36C24024K1012 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 SEPTEMBER | $953,242,300 | $953,242,300 | September 1, 2024 | September 30, 2024 | Irving, TX | usaspending.gov |
| 36C24024K1011 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 AUGUST | $943,800,292 | $943,800,292 | August 1, 2024 | August 31, 2024 | Irving, TX | usaspending.gov |
| 36C24025K1002 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 NOVEMBER | $911,976,278 | $911,976,278 | November 1, 2024 | November 30, 2024 | Irving, TX | usaspending.gov |
| 36C24024K1006 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 MARCH | $851,413,499 | $851,413,499 | March 1, 2024 | March 31, 2024 | Irving, TX | usaspending.gov |
| 36C24024K1009 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2024 JUNE | $838,785,945 | $838,785,945 | June 1, 2024 | June 30, 2024 | Irving, TX | usaspending.gov |
| 36C24025K1004 | MCKESSON CORPORATION | Department of Veterans Affairs | Delivery Order | 325412 | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 JANUARY | $715,986,475 | $715,986,475 | January 1, 2025 | January 31, 2025 | Irving, TX | usaspending.gov |
Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.